GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instituto Rosenbusch SA (BUE:ROSE) » Definitions » Cyclically Adjusted Revenue per Share

Instituto Rosenbusch (BUE:ROSE) Cyclically Adjusted Revenue per Share : ARS62.23 (As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Instituto Rosenbusch Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Instituto Rosenbusch's adjusted revenue per share for the three months ended in Dec. 2024 was ARS42.723. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ARS62.23 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Instituto Rosenbusch's average Cyclically Adjusted Revenue Growth Rate was 48.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 81.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 66.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Instituto Rosenbusch was 81.70% per year. The lowest was 47.50% per year. And the median was 79.00% per year.

As of today (2025-05-23), Instituto Rosenbusch's current stock price is ARS97.00. Instituto Rosenbusch's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 was ARS62.23. Instituto Rosenbusch's Cyclically Adjusted PS Ratio of today is 1.56.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Instituto Rosenbusch was 3.07. The lowest was 0.64. And the median was 1.24.


Instituto Rosenbusch Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Instituto Rosenbusch's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instituto Rosenbusch Cyclically Adjusted Revenue per Share Chart

Instituto Rosenbusch Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.30 10.38 18.29 41.86 62.23

Instituto Rosenbusch Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.86 47.13 52.49 58.00 62.23

Competitive Comparison of Instituto Rosenbusch's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Instituto Rosenbusch's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Instituto Rosenbusch's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Instituto Rosenbusch's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Instituto Rosenbusch's Cyclically Adjusted PS Ratio falls into.


;
;

Instituto Rosenbusch Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Instituto Rosenbusch's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=42.723/133.1571*133.1571
=42.723

Current CPI (Dec. 2024) = 133.1571.

Instituto Rosenbusch Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201503 0.616 99.621 0.823
201506 0.665 100.684 0.879
201509 0.569 100.392 0.755
201512 1.333 99.792 1.779
201603 0.960 100.470 1.272
201606 1.054 101.688 1.380
201609 1.019 101.861 1.332
201612 0.895 101.863 1.170
201703 1.058 102.862 1.370
201706 1.118 103.349 1.440
201709 0.755 104.136 0.965
201712 3.502 104.011 4.483
201803 1.500 105.290 1.897
201806 1.707 106.317 2.138
201809 2.395 106.507 2.994
201812 5.726 105.998 7.193
201903 2.692 107.251 3.342
201906 2.974 108.070 3.664
201909 3.549 108.329 4.362
201912 3.950 108.420 4.851
202003 3.263 108.902 3.990
202006 4.777 108.767 5.848
202009 5.533 109.815 6.709
202012 6.225 109.897 7.543
202103 6.101 111.754 7.269
202106 6.764 114.631 7.857
202109 6.528 115.734 7.511
202112 12.240 117.630 13.856
202203 10.575 121.301 11.609
202206 5.833 125.017 6.213
202209 5.467 125.227 5.813
202212 52.770 125.222 56.114
202303 30.825 127.348 32.231
202306 53.793 128.729 55.644
202309 48.878 129.860 50.119
202312 98.031 129.419 100.862
202403 46.012 131.776 46.494
202406 51.584 132.554 51.819
202409 53.979 133.029 54.031
202412 42.723 133.157 42.723

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Instituto Rosenbusch  (BUE:ROSE) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Instituto Rosenbusch's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=97.00/62.23
=1.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Instituto Rosenbusch was 3.07. The lowest was 0.64. And the median was 1.24.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Instituto Rosenbusch Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Instituto Rosenbusch's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Instituto Rosenbusch Business Description

Industry
Traded in Other Exchanges
N/A
Address
Hipolito Yrigoyen 1628, Buenos Aires, ARG, C1089AAF
Instituto Rosenbusch SA is a pharmaceutical company based in Argentina. The company is engaged in the processing and industrialization of biological, chemical, pharmaceutical products of any kind, nature or destination, preferably for veterinary use or intended to combat pests and diseases of the agricultural exploitation. The company has line of products such as Biologicals and pharmaceuticals. Biologicals offer Campy 3, Cultivac 6M and Bovine Antibrucelosis. Pharmaceuticals offer Diclosan A Intrammamary, Diclosan S Intrammamary and Mastilina V-S.